SOURCE: TomoTherapy


September 10, 2009 16:00 ET

TomoTherapy to Offer Advanced Radiation Therapy Solution to GNYHA Services Member Hospitals

MADISON, WI--(Marketwire - September 10, 2009) - TomoTherapy Incorporated (NASDAQ: TOMO), maker of the TomoTherapy® treatment system for advanced, CT-guided radiation therapy, announced today that it has signed an equipment supply group purchasing agreement with GNYHA Services, Inc. Pursuant to this agreement, TomoTherapy technology will be made available at contracted rates to more than 220 member hospitals in New York, New Jersey, Pennsylvania and Puerto Rico.

Fred Robertson, TomoTherapy CEO, said, "It is an honor to work with GNYHA Services, the largest regional group purchasing organization in the country. GNYHA Services is committed to helping its member hospitals improve healthcare quality. The TomoTherapy treatment system will certainly help GNYHA Services fulfill this goal."

GNYHA Services was founded in 1978 as the for-profit group purchasing arm of the Greater New York Hospital Association (GNYHA), a trade association that dates back to 1904.

In 1996, GNYHA Services partnered with Premier Purchasing Partners, L.L.P., one of the largest voluntary healthcare alliances in the U.S., to offer unsurpassed value and financial return to its members through access to Premier's comprehensive contract portfolio. Through the oversight of Giuliani Partners, L.L.C., this relationship was extended in 2004, with a renewed focus on flexibility in regionally-enhanced and direct contracting by GNYHA.

About GNYHA Services

GNYHA Services offers a robust group purchasing program and in-field customer service and value analysis, operational efficiency, utilization, and clinical educational services among many member benefits to more than 220 member hospitals in New York, New Jersey, Pennsylvania, and Puerto Rico. GNYHA Services strives every day to ensure that their members get the best supply prices from a wide variety of vendors, but also constantly work on developing solutions that address all of members supply chain needs -- beyond just purchasing. More information can be found at

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit

©2009 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.

Contact Information

  • Investor Contact:
    Thomas E. Powell
    Chief Financial Officer
    Email Contact

    Media Contacts:
    Kevin O'Malley
    Manager, Corporate Communications
    Email Contact

    Susan Lehman
    Rockpoint Public Relations
    Email Contact